Grant: Operating Grant
University of British Columbia
$222,084.00
For Whom the Bill Tolls: Private Drug Insurance in Canada
FY 2009-10
Summary
Canadians pay for prescription drugs through a patchwork of mechanisms, including public drug programs, private drug insurance and out-of-pocket payments. In 2008, private insurers paid $9.3 billion in drug costs, representing 31% of overall expenditure. Despite this, we have little sense for the structure of private health benefits plans and how they are changing in response to the current recession and significant payment modifications in public plans. We believe that private sector benefits have changed to shift more burden of payment onto individuals, through a decrease in the generosity of benefits and/or a loss in benefits coverage. We will investigate trends and influences on the generosity of private drug insurance benefits, in particular retiree benefits.
Department
Program
Operating Grant
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
201106
Name
Law Michael R
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Health Services and Policy Research
Theme2
Health systems / services
Prcname2
Health Services Evaluation & Interventions Research 3
Projecttitle
For Whom the Bill Tolls: Private Drug Insurance in Canada
Programtype2
Operating Grants
Orgnameinp2
University of British Columbia
Cihramount2
$222,084
Cihrequipment2
$0
Programname2
Operating Grant
Keyworddelim
Access To Care; Drug Use And Costs; Employer-Sponsored Health Benefits; Health Care Expenditure; Health Insurance; Pharmaceutical Policy; Policy Evaluation; Retiree Benefits
Abstract
Canadians pay for prescription drugs through a patchwork of mechanisms, including public drug programs, private drug insurance and out-of-pocket payments. In 2008, private insurers paid $9.3 billion in drug costs, representing 31% of overall expenditure. Despite this, we have little sense for the structure of private health benefits plans and how they are changing in response to the current recession and significant payment modifications in public plans. We believe that private sector benefits have changed to shift more burden of payment onto individuals, through a decrease in the generosity of benefits and/or a loss in benefits coverage. We will investigate trends and influences on the generosity of private drug insurance benefits, in particular retiree benefits.
Competitiondate
201003
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Law, Michael R
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $222,084~ $0~
